News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
801,681 Results
Type
Article (60676)
Company Profile (411)
Press Release (740571)
Multimedia
Podcasts (149)
Webinars (25)
Section
Business (218969)
Career Advice (2316)
Deals (37623)
Drug Delivery (157)
Drug Development (86386)
Employer Resources (180)
FDA (17815)
Job Trends (16312)
News (371683)
Policy (36697)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (2)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (4)
2027 Genetown Standard (2)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (5)
Academia (2961)
Academic (1)
Accelerated approval (49)
Adcomms (36)
Allergies (183)
Alliances (53722)
ALS (224)
Alzheimer's disease (1911)
Antibody-drug conjugate (ADC) (495)
Approvals (18175)
Artificial intelligence (757)
Autoimmune disease (320)
Automation (59)
Bankruptcy (380)
Best Places to Work (12440)
BIOSECURE Act (23)
Biosimilars (236)
Biotechnology (268)
Bladder cancer (203)
Brain cancer (80)
Breast cancer (792)
Cancer (6167)
Cardiovascular disease (516)
Career advice (1971)
Career pathing (47)
CAR-T (356)
CDC (69)
Celiac Disease (3)
Cell therapy (969)
Cervical cancer (49)
Clinical research (74571)
Collaboration (2236)
Company closure (6)
Compensation (1453)
Complete response letters (90)
COVID-19 (2960)
CRISPR (120)
C-suite (1220)
Cystic fibrosis (162)
Data (8226)
Decentralized trials (3)
Denatured (53)
Depression (182)
Dermatology (89)
Diabetes (621)
Diagnostics (7369)
Digital health (60)
Diversity (13)
Diversity, equity & inclusion (47)
Drug discovery (356)
Drug pricing (233)
Drug shortages (37)
Duchenne muscular dystrophy (293)
Earnings (96330)
Editorial (73)
Employer branding (23)
Employer resources (159)
Events (130075)
Executive appointments (1154)
FDA (21713)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (18)
Frontotemporal dementia (36)
Funding (1841)
Gene editing (260)
Generative AI (68)
Gene therapy (792)
GLP-1 (1192)
Government (5400)
Grass and pollen (8)
Guidances (412)
Healthcare (20814)
HIV (87)
Huntington's disease (58)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (100)
Immunology and inflammation (327)
Immuno-oncology (103)
Indications (197)
Infectious disease (3327)
Inflammatory bowel disease (234)
Inflation Reduction Act (15)
Influenza (143)
Intellectual property (299)
Interviews (360)
IPO (17369)
IRA (58)
Job creations (4213)
Job search strategy (1648)
JPM (63)
Kidney cancer (20)
Labor market (103)
Layoffs (621)
Leadership (46)
Legal (8968)
Liver cancer (106)
Longevity (33)
Lung cancer (815)
Lymphoma (441)
Machine learning (63)
Management (60)
Manufacturing (1122)
MASH (204)
Medical device (15131)
Medtech (15266)
Mergers & acquisitions (21532)
Metabolic disorders (1633)
mRNA (237)
Multiple sclerosis (195)
NASH (19)
Neurodegenerative disease (459)
Neuropsychiatric disorders (116)
Neuroscience (3534)
Neurotech (1)
NextGen: Class of 2026 (7269)
Non-profit (4964)
Now hiring (78)
Obesity (779)
Opinion (334)
Ovarian cancer (234)
Pain (272)
Pancreatic cancer (321)
Parkinson's disease (390)
Partnered (35)
Patents (615)
Patient recruitment (707)
Peanut (66)
People (64131)
Pharmaceutical (78)
Pharmacy benefit managers (35)
Phase 1 (23226)
Phase 2 (32682)
Phase 3 (24404)
Pipeline (9128)
Policy (364)
Postmarket research (2950)
Preclinical (10109)
Press Release (71)
Prostate cancer (324)
Psychedelics (61)
Radiopharmaceuticals (351)
Rare diseases (1170)
Real estate (6615)
Recruiting (73)
Regulatory (28080)
Reports (56)
Research institute (2688)
Resumes & cover letters (390)
Rett syndrome (39)
RNA editing (26)
RSV (92)
Schizophrenia (188)
Series A (311)
Series B (227)
Service/supplier (14)
Sickle cell disease (122)
Special edition (27)
Spinal muscular atrophy (180)
Sponsored (51)
Startups (4044)
State (2)
Stomach cancer (21)
Supply chain (134)
Tariffs (96)
The Weekly (93)
Vaccines (1206)
Venture capital (118)
Weight loss (527)
Women's health (134)
Worklife (22)
Date
Last 7 days (709)
Last 30 days (3392)
Last 365 days (31749)
2026 (13798)
2025 (31904)
2024 (37148)
2023 (42141)
2022 (53451)
2021 (58238)
2020 (57081)
2019 (50380)
2018 (38179)
2017 (34942)
2016 (35181)
2015 (41168)
2014 (34892)
2013 (30490)
2012 (32633)
2011 (33246)
2010 (32392)
Location
Africa (924)
Alabama (101)
Alaska (7)
Arizona (373)
Arkansas (16)
Asia (45318)
Australia (7599)
California (13830)
Canada (3860)
China (1452)
Colorado (595)
Connecticut (610)
Delaware (422)
Europe (101956)
Florida (2065)
Georgia (453)
Hawaii (3)
Idaho (66)
Illinois (1136)
India (96)
Indiana (632)
Iowa (24)
Japan (556)
Kansas (137)
Kentucky (53)
Louisiana (46)
Maine (76)
Maryland (1683)
Massachusetts (10064)
Michigan (392)
Minnesota (772)
Mississippi (7)
Missouri (160)
Montana (37)
Nebraska (29)
Nevada (150)
New Hampshire (91)
New Jersey (3691)
New Mexico (33)
New York (3632)
North Carolina (1855)
North Dakota (11)
Northern California (6903)
Ohio (419)
Oklahoma (26)
Oregon (46)
Pennsylvania (2748)
Puerto Rico (30)
Rhode Island (52)
South America (1305)
South Carolina (88)
South Dakota (2)
Southern California (5438)
Tennessee (219)
Texas (2222)
United States (49327)
Utah (411)
Vermont (1)
Virginia (348)
Washington D.C. (85)
Washington State (1124)
West Virginia (4)
Wisconsin (139)
Wyoming (2)
801,681 Results for "repro med systems inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
TempraMed Launches New Product “VIVI Med(TM),” Unlocking New Growth Opportunities in High-Value Biologics and Injectable Medications
Using same proprietary, patented technology, VIVI Med extends the product portfolio beyond injectable pens, opening access to broader patient populations, premium biologics, and institutional channel
January 23, 2026
·
6 min read
Press Releases
Inspire Medical Systems, Inc. to Present at the BofA Securities 2026 Healthcare Conference
April 29, 2026
·
1 min read
Press Releases
VVT Med Signs Largest European Distribution Agreement to Date; Distributor Joins as Investor
April 27, 2026
·
7 min read
Press Releases
Autonomix Medical, Inc. Granted U.S. Patent for Transvascular Monitoring and Treatment Systems with Real-Time Procedural Validation
May 19, 2026
·
5 min read
Press Releases
Inspire Medical Systems, Inc. Announces First Quarter 2026 Financial Results and Updates 2026 Guidance
May 4, 2026
·
19 min read
Press Releases
Orano Announces the Appointment of Frederic Desdouits as CEO of Orano Med
April 8, 2026
·
3 min read
Press Releases
VVT Med Announces Positive Clinical Data for ScleroSafe(R) Published in Peer-Reviewed Indian Journal of Vascular and Endovascular Surgery
April 30, 2026
·
6 min read
Mergers & acquisitions
Chiesi snaps up KalVista for $1.9B, betting big on rare disease med Ekterly
Chiesi Group is taking KalVista Pharmaceuticals under its wing, paying $1.9 billion for the biotech’s oral therapy Ekterly to treat severe swelling episodes caused by the rare genetic disorder hereditary angioedema.
April 29, 2026
·
2 min read
·
Gabrielle Masson
Press Releases
Inspire Medical Systems, Inc. to Report First Quarter 2026 Financial Results on May 4, 2026
April 6, 2026
·
1 min read
Press Releases
Envoy Medical Appoints Chas McKhann to Board of Directors
Proven Med Tech Leader with an Established Track Record of Commercial Success and Optimizing Shareholder Value Leading to over $3.4 Billion in Successful Exits
April 16, 2026
·
8 min read
1 of 80,169
Next
